China is rapidly constructing extensive domestic biobanks, aiming to establish a research capacity comparable to that of the United States. This initiative is partly driven by increasing geopolitical tensions and restricted access to Western biomedical databases. Experts note the growing recognition of biodata as a strategic resource in the US, highlighting the global competition in biotechnology and the bioeconomy. AI
影响 Potential for accelerated drug discovery and development in China, impacting global pharmaceutical R&D.
排序理由 Significant geopolitical competition in a key technological area (biotechnology) between major global powers.
在 CSET (Georgetown — Center for Security & Emerging Tech) 阅读 →
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
